Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1Phase 1 1

Status

Terminated 4Completed 4Withdrawn 1Suspended 1Recruiting 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pulmonary Fibrosis 1Lung Neoplasms 1

Interventions

Cyclophosphamide 118pembrolizumab 104Specimen Handling 104Magnetic Resonance Spectroscopy 94fludarabine 92Biopsy 77Injections 53Nivolumab 43Bevacizumab 41Fluorouracil 38venetoclax 37Cisplatin 36Paclitaxel 35Carboplatin 35Cetuximab 34Radiotherapy 31Oxaliplatin 30fludarabine phosphate 29Leucovorin 28Gemcitabine 28Drug Therapy 25Ipilimumab 23Immunotherapy, Adoptive 23Azacitidine 23Radiation 21Irinotecan 21Temozolomide 20Doxorubicin 20tislelizumab 19atezolizumab 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Recruiting × Positron-Emission Tomography × Clear all
NCT03535545 2026-02-27

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

Massachusetts General Hospital

Phase 1 Recruiting
100 enrolled
Thoracic

Lung Neoplasms, Pulmonary Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡